Retirement Group’s Acadia Pharmaceuticals ACAD Stock Holding History

Retirement Group’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$1.55K	Hold	600	–	–	﹤0.01%	680
2023 Q4	$1.5K	Hold	600	–	–	﹤0.01%	663
2023 Q3	$1.22K	Hold	600	–	–	﹤0.01%	622
2023 Q2	$1.38K	Hold	600	–	–	﹤0.01%	646
2023 Q1	$2K	Hold	600	–	–	﹤0.01%	569
2022 Q4	$1K	Hold	600	–	–	﹤0.01%	553
2022 Q3	$1K	Hold	600	–	–	﹤0.01%	427
2022 Q2	$2K	Hold	600	–	–	﹤0.01%	604
2022 Q1	$2K	Hold	600	–	–	﹤0.01%	608
2021 Q4	$2K	Buy	600 +100	+20%	+$2.01K	﹤0.01%	602
2021 Q3	$2K	Sell	500 -39	-7%	-$752	﹤0.01%	510
2021 Q2	$13K	Hold	539	–	–	0.01%	377
2021 Q1	$14K	Hold	539	–	–	0.01%	431
2020 Q4	$28K	Buy	539 +285	+112%	+$14.1K	0.01%	322
2020 Q3	$10K	Buy	+254	New	+$11K	0.01%	408

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Retirement Group's ACAD Position: Q1 2024 in Review

Retirement Group held its Acadia Pharmaceuticals (ACAD) position steady in Q1 2024 at 600 shares worth $1.55K. The position accounts for ﹤0.01% of the portfolio, ranked #680.

Retirement Group first reported a position in ACAD in Q3 2020 and has held it in 15 quarters since. The position peaked at $28K in Q4 2020. 267 funds tracked by Wall St. Rank hold ACAD as of Q1 2024.

Retirement Group held 600 shares of Acadia Pharmaceuticals worth $1.55K as of Q1 2024.
Retirement Group left its Acadia Pharmaceuticals share count unchanged in Q1 2024.
Acadia Pharmaceuticals made up ﹤0.01% of Retirement Group's portfolio in Q1 2024, its #680 holding.
Retirement Group first reported a position in Acadia Pharmaceuticals in Q3 2020 and has held it in 15 quarters since.
Retirement Group's Acadia Pharmaceuticals position peaked at $28K in Q4 2020.
267 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2024.

Based on Retirement Group's 13F filing for Q1 2024, filed 30 Apr 2024.